Latest news and press releases about Precigen, Inc. (PGEN): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies.
Price
| Price | $7.43 |
| Market Cap | $2.7B |
| Exchange | NASDAQ |
| Country | US |
Related companies: AMLX · DNTH · ELVN · IMTX · NKTR · ORIC · RLAY
Explore sector: Healthcare · Biotechnology
More sections of PGEN: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks